-
-
-
-
-
-
-
Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update
-
-
-
-
-
-
-
Rhythm Pharmaceuticals and LG Chem Life Sciences Enter Agreement for Rhythm to Acquire Global Rights to Oral MC4R Agonist LB54640
-
-
-
-
-
-
-
Rhythm Pharmaceuticals Announces Updates on MC4R Pathway Programs at R&D Event
-
-
-
-
-
-
-
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
-
-
-
-
-
-
-
Pre-Open Movers: Adobe Sinks on Deal to Acquire Figma, STOR Surges on Takeover
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) Reports Election of Jennifer Good to Board
-
-
-
-
-
1,157,825 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

